DSS, INC. sold IBO
March 20, 2025 · Form 4 insider transaction
DSS, INC. sold 53,280 shares of Impact BioMedical Inc. at $4.68 per share, a transaction worth $249.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
53,280
Price
$4.68
Total value
$249.4K
InsiderDSS, INC.
Role—
CompanyImpact BioMedical Inc. (IBO)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateMarch 20, 2025
Filing dateMarch 24, 2025
Shares owned after0
OwnershipIndirect
10b5-1 planNo
AmendedNo
Footnotes
Sentinel Brokers Company, Inc. is a majority owned subsidiary of DSS, Inc.